Astrocytic APOE4 genotype-mediated negative impacts on synaptic architecture in human pluripotent stem cell model

Stem Cell Reports. 2023 Sep 12;18(9):1854-1869. doi: 10.1016/j.stemcr.2023.08.002. Epub 2023 Aug 31.

Abstract

The APOE4 genotype is the strongest risk factor for the pathogenesis of sporadic Alzheimer's disease (AD), but the detailed molecular mechanism of APOE4-mediated synaptic impairment remains to be determined. In this study, we generated a human astrocyte model carrying the APOE3 or APOE4 genotype using human induced pluripotent stem cells (iPSCs) in which isogenic APOE4 iPSCs were genome edited from healthy control APOE3 iPSCs. Next, we demonstrated that the astrocytic APOE4 genotype negatively affects dendritic spine dynamics in a co-culture system with primary neurons. Transcriptome analysis revealed an increase of EDIL3, an extracellular matrix glycoprotein, in human APOE4 astrocytes, which could underlie dendritic spine reduction in neuronal cultures. Accordingly, postmortem AD brains carrying the APOE4 allele have elevated levels of EDIL3 protein deposits within amyloid plaques. Together, these results demonstrate the novel deleterious effect of human APOE4 astrocytes on synaptic architecture and may help to elucidate the mechanism of APOE4-linked AD pathogenesis.

Keywords: APOE; Alzheimer’s disease; apolipoprotein E; astrocyte; iPSCs; induced pluripotent stem cells.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Apolipoprotein E3 / genetics
  • Apolipoprotein E4 / genetics
  • Astrocytes
  • Calcium-Binding Proteins
  • Cell Adhesion Molecules
  • Genotype
  • Humans
  • Induced Pluripotent Stem Cells*
  • Pluripotent Stem Cells*

Substances

  • Apolipoprotein E3
  • Apolipoprotein E4
  • Calcium-Binding Proteins
  • Cell Adhesion Molecules
  • EDIL3 protein, human
  • ApoE protein, human